Drug factory · FDA FEI 3001231132
Lucideon Limited
STONE BUSINESS PARK BROOMS ROAD, Stone, United Kingdom
Problems found, fixed voluntarily at FDA's last inspection, Feb 29, 2024.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
1 drug inspection on record since 2024: 0 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Avapritinib | Tests it | Blueprint Medicines Corporation | 72064-110, 72064-120, 72064-130 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Feb 29, 2024 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis.